arrow
P

Pierre Morel

amiens university hospital
H指数:52
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lenalidomide maintenance after initial immunochemotherapy in chronic lymphocytic leukaemia—Final analysis of the international phase III CLL6 RESIDUUM study of the ALLG and FILO groups

慢性淋巴细胞白血病初始免疫化疗后的来那度胺维持治疗——ALLG和FILO国际III期CLL6研究RESIDUUM部分的最终分析

2026-09-210
OAAI
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia

POD24是沃尔德斯特伦巨球蛋白血症患者预后的新型决定因素。

2026-01-090
OAAI
Waldenström’s macroglobulinemia: the LYSA pragmatic guidelines

华氏巨球蛋白血症:LYSA实用指南

2025-11-280
PRE
Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma

更正:不同的分子通路驱动单形态上皮表型肠道T细胞淋巴瘤和肠病相关肠道T细胞淋巴瘤。

Leukemia
IF13.4
2025-11-200
OAAI
Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma

分歧的分子通路驱动单形态上皮亲嗜性及肠病相关肠道T细胞淋巴瘤

Leukemia
IF13.4
2025-10-070
OA
Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial

脆弱及新诊断多发性骨髓瘤患者中地塞米松减量方案联合达拉珠单抗和来那度胺的安全性与有效性(IFM2017-03):一项III期、开放标签、多中心、随机对照试验

2025-09-290
OAAI
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease

第十二届华氏巨球蛋白血症国际研讨会第三共识小组关于高风险疾病患者管理的报告

2025-04-080
PRE
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia
2024-11-050
OAAI
Circulating tumor cells in Waldenström macroglobulinemia
LEUKEMIA
IF13.4
2024-02-090
PRE
Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

严重成人噬血细胞性淋巴组织细胞增生症 (HLHa) 与HLH相关基因变异相关

2024-01-016
OAAI
SARS-CoV-2 Infection in Patients With Waldenstrom's Macroglobulinemia: A Multicenter International Cohort Study
2023-06-011
OAAI
Diagnostics in Waldenstrom's macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom's Macroglobulinemia
LEUKEMIA
IF13.4
2022-11-2622
OAAI
High frequency of central nervous system involvement in transformed Waldenstrom macroglobulinemia
2022-06-215
OAAI
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome
2022-06-1634
OAAI
The EHA Research Roadmap: Malignant Lymphoid Diseases

EHA研究路线图: 恶性淋巴疾病

2022-06-013
OAAI